Navigation Links
Synthetic Protein Eases Arthritis Symptoms in Mice

A lab-made version of a human protein alleviates symptoms of both acute and chronic arthritis in mice and could be the basis for a new arthritis drug for people, report scientists from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH). The protein prevents the assembly of a cell surface receptor, thus blocking transmission of chemical signals that lead to arthritis symptoms.

“This study opens a new research avenue to better understand and, perhaps, to treat rheumatoid arthritis, a condition that causes suffering in more than two million Americans,?says NIAID Director Anthony S. Fauci, M.D.

Investigators from NIAID’s Laboratory of Immunology, led by Michael Lenardo, M.D., published their findings in the October issue of Nature Medicine, now available online. The idea that the protein, called pre-ligand assembly domain protein or PLAD, might play a role in thwarting the joint inflammation characteristic of rheumatoid arthritis ?one of the most common autoimmune diseases ?grew out of their research on a very rare autoimmune disease called autoimmune lymphoproliferative syndrome (ALPS).

Previously, Dr. Lenardo and his colleagues showed that in ALPS a form of PLAD blocks a cell surface receptor and prevents a needed chemical signaling pathway from functioning correctly. In ALPS, the signal pathway interrupted by PLAD leads to disease symptoms. But, the scientists reasoned, PLAD might also be able to block a related cell surface receptor ?one involved in passing signals that lead to inflammation. In theory, inhibiting this pathway might benefit people with rheumatoid arthritis, who suffer from excessive inflammation.

A key promoter of inflammation is a chemical called tumor necrosis factor alpha (TNF-alpha). TNF-alpha starts a chemical chain reaction leading to inflammation by binding to two cell surface receptors, TNFR-1 and TNFR-2. Naturally occurring PLAD helps both forms of
'"/>

Source:NIH


Page: 1 2

Related biology news :

1. Synthetic molecule causes cancer cells to self-destruct
2. Synthetic peptide targets latent papilloma virus infections
3. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
4. Protein discovery could unlock the secret to better TB treatment
5. Researchers Uncover Key Step In Manufacture of Memory Protein
6. An HIV Protein Plays a Surprising Role in Gene Activation
7. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
8. New SARS Protein Linked To Important Cell Doorway
9. The Shapes Of Life: NIGMS Project Yields More Than 1,000 Protein Structures
10. PANTHER Protein Classification System Database 5.0
11. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Synthetic Protein Eases Arthritis Symptoms Mice

(Date:6/17/2013)... 2013 An international team led by scientists at ... Institute and Albert Einstein College of Medicine of Yeshiva ... that attacks the tuberculosis (TB) bacterium in two different ... solve one of the major global health crises of ... strains," said Peter G. Schultz, the Scripps Family Chair ...
(Date:6/17/2013)... professors in Wayne State University,s Department of Physics ... Research Experience for Undergraduates (REU) program. This program ... cutting-edge research in astrophysics, and in particle and ... Ph.D., professor of physics in Wayne State,s College ... director of the grant, the student participants will ...
(Date:6/17/2013)... foundations with more modern elements. Using this same approachbut ... Dietrich School of Arts and Sciences have designed a ... storage, and gas transport more efficient and at a ... issue of the Journal of the American Chemical ... builds upon Pitt Associate Professor of Chemistry Nathaniel Rosi,s ...
Breaking Biology News(10 mins):New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4Wayne State welcomes undergraduates from around the US for physics research experience 2'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... DNA mutations may shepherd in an era of small, ... of genes that harbor disease. , Joseph Wang, director ... Biodesign Institute at ASU, led a team effort that ... and nanotechnology to fashion nanocrystals that can act as ...
... the plagues of the Middle Ages have made around 10% ... time that these individuals carry a genetic mutation (known as ... the immune system but have been unable to account for ... low levels in areas bordering the Mediterranean. , They have ...
... team of researchers at Johns Hopkins Medical Institutions in ... (PET/CT) scans may help physicians identify new, unexpected malignant ... the May issue of the Society of Nuclear Medicine's ... additional lesions in patients known to have cancer," said ...
Cached Biology News:Bioelectronic ‘signatures?hold key to DNA mutations 2First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes 2PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment 2
(Date:6/17/2013)... June 17, 2013 Z Trim Holdings, ... company providing value-added ingredients to a variety of ... a new meat application at this year,s annual ... Chicago , July 13-16. The Company ... more expensive/chemically-modified ingredients in meat products thereby helping ...
(Date:6/17/2013)... 17, 2013 Yongye International, Inc. (NASDAQ:   ... and distributor of crop nutrient products in ... today that its common stock will resume trading on ... at 7:15 a.m. Eastern Time. As previously ... Monday, March 18, 2013 following Yongye,s notification that the ...
(Date:6/16/2013)... CO (PRWEB) June 16, 2013 This training ... the Scrum team, people outside the software industry or those ... of what it is. , The topics that will ... scrum framework, scrum roles, scrum meetings, scrum artifacts, and scrum ... the following cities: , Denver, CO June 28, 2013 , ...
(Date:6/14/2013)... Case Western Reserve University, in collaboration ... has been awarded a $3 million grant from ... neurostimulation technology platform designed to treat multiple clinical ... muscle paralysis. , The Ohio Third ... the technology development and innovation capabilities of Ohio’s ...
Breaking Biology Technology:Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 2Z Trim to Spotlight New Meat Applications at IFT 2013 in Chicago 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 2Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 4Affordable Scrum Trainings in Denver, CO – 8 PDUs (June 28, 2013) by Conscires Agile Practices 2Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission 2Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission 3Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission 4
... SANTA BARBARA, Calif., Nov. 15, 2011 FindTheBest,s Private ... parents seeking an accredited storage facility for their newborn,s cord ... and highly sensitive decision to make, particularly for families with ... parents a way to make the most informed decision when ...
... N.J., Nov. 15, 2011 Palatin Technologies, Inc. (NYSE ... targeted, receptor-specific peptide therapeutics for the treatment of diseases ... announced results for its first quarter ended September 30, ... or $(0.10) per basic and diluted share, for the ...
... 2011 A new retrospective subanalysis ... mesylate) capsules 150mg twice daily reduced the risk ... in patients with non-valvular atrial fibrillation (NVAF) irrespective ... with no significant interaction for major bleeding events.(1) ...
Cached Biology Technology:Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 2Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 4Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 5New Subanalyses of RE-LY® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation 2New Subanalyses of RE-LY® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation 3New Subanalyses of RE-LY® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation 4New Subanalyses of RE-LY® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation 5New Subanalyses of RE-LY® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation 6New Subanalyses of RE-LY® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation 7New Subanalyses of RE-LY® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation 8
...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: